T0	Participants 138 176	Resected stage III cutaneous melanoma.
T1	Participants 226 267	patients with resected stage III melanoma
T2	Participants 433 536	Ad Hoc Melanoma Working Group of 25 investigators treated 604 patients from April 1997 to January 2003.